IP
IBB icon

Intellectus Partners’s iShares Biotechnology ETF IBB Stock Holding History

Intellectus Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Sell
12,950
-150
-1% -$25.8K 0.43% 56
2026
Q1 		$2.21M Sell
13,100
-48
-0.4% -$8.21K 0.45% 57
2025
Q4 		$2.22M Buy
13,148
+3
+0% +$487 0.43% 62
2025
Q3 		$1.9M Buy
13,145
+51
+0.4% +$6.96K 0.37% 73
2025
Q2 		$1.66M Sell
13,094
-70
-0.5% -$8.59K 0.36% 77
2025
Q1 		$1.68M Sell
13,164
-597
-4% -$81K 0.42% 68
2024
Q4 		$1.82M Buy
13,761
+56
+0.4% +$7.87K 0.4% 68
2024
Q3 		$2M Sell
13,705
-1,051
-7% -$152K 0.51% 56
2024
Q2 		$2.03M Sell
14,756
-2,004
-12% -$268K 0.55% 47
2024
Q1 		$2.3M Sell
16,760
-2,256
-12% -$308K 0.6% 45
2023
Q4 		$2.58M Sell
19,016
-483
-2% -$58.9K 0.75% 30
2023
Q3 		$2.39M Sell
19,499
-861
-4% -$109K 0.76% 34
2023
Q2 		$2.58M Sell
20,360
-2,148
-10% -$279K 0.78% 35
2023
Q1 		$2.91M Buy
22,508
+1,502
+7% +$197K 0.92% 26
2022
Q4 		$2.76M Sell
21,006
-596
-3% -$77K 0.96% 25
2022
Q3 		$2.53M Sell
21,602
-735
-3% -$91.3K 0.9% 25
2022
Q2 		$2.63M Sell
22,337
-649
-3% -$77K 0.9% 26
2022
Q1 		$3M Buy
22,986
+1,979
+9% +$258K 0.89% 24
2021
Q4 		$3.21M Sell
21,007
-1,080
-5% -$167K 0.82% 27
2021
Q3 		$3.57M Sell
22,087
-798
-3% -$134K 0.86% 24
2021
Q2 		$3.75M Sell
22,885
-814
-3% -$125K 0.84% 22
2021
Q1 		$3.57M Sell
23,699
-63
-0.3% -$10K 0.98% 17
2020
Q4 		$3.6M Buy
23,762
+562
+2% +$80.3K 1.08% 16
2020
Q3 		$3.14M Buy
23,200
+1,616
+7% +$219K 1.19% 17
2020
Q2 		$2.95M Buy
21,584
+1,412
+7% +$180K 1.14% 18
2020
Q1 		$2.17M Sell
20,172
-1,048
-5% -$121K 1.04% 23
2019
Q4 		$2.56M Buy
21,220
+561
+3% +$62.6K 1.04% 23
2019
Q3 		$2.06M Sell
20,659
-864
-4% -$90.4K 0.9% 24
2019
Q2 		$2.35M Sell
21,523
-1,463
-6% -$156K 1.02% 18
2019
Q1 		$2.57M Buy
+22,986
New +$2.52M 1.11% 15
2018
Q4 		– Sell
-29,520
Closed -$3.6M – 376
2018
Q3 		$3.6M Buy
29,520
+372
+1% +$43.8K 1.26% 11
2018
Q2 		$3.21M Buy
29,148
+346
+1% +$37K 1.17% 12
2018
Q1 		$3.07M Buy
28,802
+1,245
+5% +$138K 1.06% 15
2017
Q4 		$2.94M Buy
27,557
+1,244
+5% +$133K 1.1% 14
2017
Q3 		$2.93M Hold
26,313
– – 1.21% 11
2017
Q2 		$2.72M Buy
26,313
+1,800
+7% +$177K 1.22% 13
2017
Q1 		$2.4M Buy
24,513
+582
+2% +$55.7K 1.22% 11
2016
Q4 		$2.12M Buy
+23,931
New +$2.18M 1.1% 13

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Intellectus Partners's IBB Position: Q2 2026 in Review

Intellectus Partners reduced its iShares Biotechnology ETF (IBB) stake by 1.1% in Q2 2026, selling an estimated $25.8K and leaving 12,950 shares worth $2.46M. The position accounts for 0.43% of the portfolio, ranked #56.

Intellectus Partners first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. The position peaked at $3.75M in Q2 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Intellectus Partners held 12,950 shares of iShares Biotechnology ETF worth $2.46M as of Q2 2026.
  • Intellectus Partners sold 150 iShares Biotechnology ETF shares in Q2 2026, an estimated $25.8K.
  • iShares Biotechnology ETF made up 0.43% of Intellectus Partners's portfolio in Q2 2026, its #56 holding.
  • Intellectus Partners first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
  • Intellectus Partners's iShares Biotechnology ETF position peaked at $3.75M in Q2 2021.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Intellectus Partners's 13F filing for Q2 2026, filed 12 Aug 2026.